Clinical trials
Community-Acquired Pneumonia trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
57 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 57 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Capital Medical University | 4 |
| Assiut University | 3 |
| Hannover Medical School | 2 |
| Peking Union Medical College Hospital | 2 |
| Shanghai Children's Medical Center | 2 |
| University of Roma La Sapienza | 2 |
| Asian Foundation for Tropical Medicine Inc. | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beaumont Hospital | 1 |
| Beijing Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Community-Acquired Pneumonia | 57 |
| Pneumonia | 9 |
| Pneumonia, Viral | 4 |
| Healthcare-Associated Pneumonia | 3 |
| Pneumonia, Bacterial | 3 |
| Sepsis | 3 |
| Bronchitis | 2 |
| COVID-19 | 2 |
| Infections | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
Trials
Showing 76 to 57 of 57. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.